Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

Similar articles for PubMed (Select 9833881)


LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression.

Quiñones-Mateu ME, Mas A, Lain de Lera T, Soriano V, Alcamí J, Lederman MM, Domingo E.

Virus Res. 1998 Sep;57(1):11-20.


Sequence heterogeneity in human immunodeficiency virus type 1 nef in patients presenting with rapid progression and delayed progression to AIDS.

Gupta P, Husain M, Hans C, Ram H, Verma SS, Misbah M, Chauhan LS, Rai A.

Arch Virol. 2014 Sep;159(9):2303-20. doi: 10.1007/s00705-014-2026-2. Epub 2014 Apr 19.


Molecular and genetic characterization of natural HIV-1 Tat Exon-1 variants from North India and their functional implications.

Ronsard L, Lata S, Singh J, Ramachandran VG, Das S, Banerjea AC.

PLoS One. 2014 Jan 23;9(1):e85452. doi: 10.1371/journal.pone.0085452. eCollection 2014.


Study of the HIV-2 Env cytoplasmic tail variability and its impact on Tat, Rev and Nef.

Bakouche N, Vandenbroucke AT, Goubau P, Ruelle J.

PLoS One. 2013 Nov 1;8(11):e79129. doi: 10.1371/journal.pone.0079129. eCollection 2013.


Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.

Ghezzi S, Galli L, Kajaste-Rudnitski A, Turrini F, Marelli S, Toniolo D, Casoli C, Riva A, Poli G, Castagna A, Vicenzi E.

AIDS. 2013 Sep 24;27(15):2335-44. doi: 10.1097/01.aids.0000432474.76873.5f.


Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patients.

Bona R, Baroncelli S, D'Ettorre G, Andreotti M, Ceccarelli G, Filati P, Leone P, Blasi M, Michelini Z, Galluzzo CM, Mallano A, Vullo V, Cara A.

AIDS Res Hum Retroviruses. 2013 Oct;29(10):1365-9. doi: 10.1089/AID.2013.0047. Epub 2013 Jul 24.


Impact of the DNA extraction method on 2-LTR DNA circle recovery from HIV-1 infected cells.

Badralmaa Y, Natarajan V.

J Virol Methods. 2013 Oct;193(1):184-9. doi: 10.1016/j.jviromet.2013.06.014. Epub 2013 Jun 15.


tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.

Rossenkhan R, MacLeod IJ, Sebunya TK, Castro-Nallar E, McLane MF, Musonda R, Gashe BA, Novitsky V, Essex M.

J Virol. 2013 May;87(10):5732-45. doi: 10.1128/JVI.03297-12. Epub 2013 Mar 13.


Variation of HIV-1 mutation spectra among cell types.

Holtz CM, Mansky LM.

J Virol. 2013 May;87(9):5296-9. doi: 10.1128/JVI.03576-12. Epub 2013 Feb 28.


Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase.

Mariyanna L, Priyadarshini P, Hofmann-Sieber H, Krepstakies M, Walz N, Grundhoff A, Buchholz F, Hildt E, Hauber J.

PLoS One. 2012;7(2):e31576. doi: 10.1371/journal.pone.0031576. Epub 2012 Feb 13.


[Analysis of genetic diversity and amino acid sequence of HIV-1tat in CNS and peripheral tissue of a patient with ADC and a patient with non-ADC].

Pu SS, Li YP, Yan YF, Wen HL, Wang ZY, Song YY, Xu HZ, Zhao L.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Aug;25(4):251-3. Chinese.


Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment.

Li L, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Wojno A, Passic S, Flaig K, Kilareski E, Blakey B, Ku J, Parikh N, Shah R, Martin-Garcia J, Moldover B, Servance L, Downie D, Lewis S, Jacobson JM, Kolson D, Wigdahl B.

J Neurovirol. 2011 Feb;17(1):92-109. doi: 10.1007/s13365-010-0014-1. Epub 2011 Jan 12.


Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia.

Cowley D, Gray LR, Wesselingh SL, Gorry PR, Churchill MJ.

J Neurovirol. 2011 Feb;17(1):70-81. doi: 10.1007/s13365-010-0002-5. Epub 2010 Nov 30.


In vitro evolution and analysis of HIV-1 LTR-specific recombinases.

Buchholz F, Hauber J.

Methods. 2011 Jan;53(1):102-9. doi: 10.1016/j.ymeth.2010.06.014. Epub 2010 Jun 26. Review.


Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells.

Reigadas S, Andréola ML, Wittkop L, Cosnefroy O, Anies G, Recordon-Pinson P, Thiébaut R, Masquelier B, Fleury H.

J Antimicrob Chemother. 2010 Mar;65(3):434-7. doi: 10.1093/jac/dkp473. Epub 2010 Jan 5.


Molecular characterization of tat gene and long terminal repeat region of human immunodeficiency virus type-1 detected among the injecting drug users (IDUs) of Manipur, India: identification of BC recombinants.

Mullick R, Sengupta S, Sarkar K, Chakrabarti S.

Virus Res. 2010 Feb;147(2):195-201. doi: 10.1016/j.virusres.2009.10.024. Epub 2009 Nov 6.


Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children.

Tzitzivacos DB, Tiemessen CT, Stevens WS, Papathanasopoulos MA.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1141-8. doi: 10.1089/aid.2009.0080.


In vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expression.

Carobene MG, Rodríguez Rodrígues C, De Candia CA, Turk G, Salomón H.

Virol J. 2009 Jul 16;6:107. doi: 10.1186/1743-422X-6-107.


High frequency of gross deletions in the 5' LTR and gag regions in HIV type 1-infected long-term survivors treated with Korean red ginseng.

Cho YK, Jung YS.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):181-93. doi: 10.1089/aid.2007.0143.


Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.

Nevado J, Tenbaum SP, Castillo AI, Sánchez-Pacheco A, Aranda A.

J Mol Endocrinol. 2007 Jun;38(6):587-601.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk